U.S. FDA authorizes emergency use of experimental antibody drug Trump took

The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc. drug to try to prevent hospitalization and worsening disease from developing in patients with mild-to-moderate symptoms.

Read More


READ:  Texas calls in National Guard to help morgues overwhelmed by coronavirus deaths
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker